Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: The Journal of Sexual Medicine, 8, 5, S. 1486-1494
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2011
- Event
-
Veröffentlichung
- (where)
-
Oxford
- (who)
-
Oxford University Press
- (when)
-
2011
- Creator
-
Ochsenkühn, Robert
Hermelink, Kerstin
Clayton, Anita H.
von Schönfeldt, Viktoria
Gallwas, Julia
Ditsch, Nina
Rogenhofer, Nina
Kahlert, Steffen
- DOI
-
10.1111/j.1743-6109.2011.02220.x
- URN
-
urn:nbn:de:bvb:384-opus4-844129
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ochsenkühn, Robert
- Hermelink, Kerstin
- Clayton, Anita H.
- von Schönfeldt, Viktoria
- Gallwas, Julia
- Ditsch, Nina
- Rogenhofer, Nina
- Kahlert, Steffen
- Universität Augsburg
- Oxford University Press
Time of origin
- 2011
Other Objects (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Atlas der Brustchirurgie : Operationstechniken Step by Step
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Immunotherapy: new options in breast cancer treatment
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Atlas der Brustchirurgie : Operationstechniken Step by Step
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Immunotherapy: new options in breast cancer treatment
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Atlas der Brustchirurgie : Operationstechniken Step by Step
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations